• Return to Headlines

Exelixis Inc Has Returned 39.9% Since SmarTrend Recommendation (EXEL)

By Shiri Gupta

SmarTrend identified an Uptrend for Exelixis Inc (NASDAQ:EXEL) on June 19th, 2017 at $20.72. In approximately 3 months, Exelixis Inc has returned 39.90% as of today's recent price of $28.98.

In the past 52 weeks, Exelixis Inc share prices have been bracketed by a low of $7.20 and a high of $29.50 and are now at $28.98, 303% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.3%.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Exelixis Inc shares.

Log in and add Exelixis Inc (EXEL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exelixis inc

Ticker(s): EXEL